Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029137
Filing Date
2025-02-27
Accepted
2025-02-27 16:30:39
Documents
119
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K orgo-20241231.htm   iXBRL 10-K 3783584
2 EX-4.1 orgo-ex4_1.htm EX-4.1 60456
3 EX-10.35 orgo-ex10_35.htm EX-10.35 732672
4 EX-10.36 orgo-ex10_36.htm EX-10.36 52176
5 EX-10.37 orgo-ex10_37.htm EX-10.37 21804
6 EX-19.1 orgo-ex19_1.htm EX-19.1 183394
7 EX-21.1 orgo-ex21_1.htm EX-21.1 7540
8 EX-23.1 orgo-ex23_1.htm EX-23.1 5102
9 EX-31.1 orgo-ex31_1.htm EX-31.1 13595
10 EX-31.2 orgo-ex31_2.htm EX-31.2 13684
11 EX-32.1 orgo-ex32_1.htm EX-32.1 9084
12 GRAPHIC img154857153_0.jpg GRAPHIC 382345
13 GRAPHIC img248015970_0.jpg GRAPHIC 90888
  Complete submission text file 0000950170-25-029137.txt   17369935

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20241231.xsd EX-101.SCH 2089510
122 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20241231_htm.xml XML 2800592
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37906 | Film No.: 25679578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)